Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms

Nanomedicine : Nanotechnology, Biology, and Medicine
Yan-Qiong ZhangThomas J Webster

Abstract

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. Current therapies present significant limitations. Triptolide (TP) is highly effective against multiple cancers including HCC. However, high toxicity, low water solubility, and unknown therapeutic targets limit its clinical application. Herein, we designed galactosylated-chitosan-TP-nanoparticles (GC-TP-NPs) with high drug loading capacities for targeted delivery to HCC. In addition to a sustained release pattern, an efficient asialoglycoprotein receptor mediated cellular uptake in vitro, and high liver tumor accumulation in vivo, GC-TP-NPs showed lower systemic and male reproductive toxicities than free TP. Importantly, GC-TP-NPs retained the anti-cancer activities of the free TP, exerting the same pro-apoptotic and anti-proliferative effects on HCC cells in vitro, and displayed higher efficacies in reducing tumor sizes in vivo. Further investigation revealed that GC-TP-NPs induced cancer cell apoptosis via blocking TNF/NF-κB/BCL2 signaling. Collectively, GC-TP-NP represents a promising candidate in halting liver cancer progression while minimizing systemic toxicity.

Citations

Jan 31, 2020·Expert Opinion on Drug Delivery·Dina A HafezAhmed O Elzoghby
Apr 2, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pasquale SaccoIvan Donati
Jul 8, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Li QiaoQingcong Wei
Dec 19, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anroop B NairKatharigatta N Venugopala
Nov 5, 2020·Natural Product Reports·Lu TongJun O Liu
Dec 3, 2020·Journal of Nanobiotechnology·Anna FlorczakHanna Dams-Kozlowska
Dec 9, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kevin LiawRangaramanujam M Kannan
Jan 24, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Qing RenJun Lu
Feb 2, 2021·International Journal of Biological Macromolecules·Fatemeh GhahremanzadehDariush Semnani
Nov 15, 2019·Current Topics in Medicinal Chemistry·Sachin KumarHimangini Bansal
Aug 30, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Keenan J Mintz, Roger M Leblanc

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.